0001179110-18-002364.txt : 20180220
0001179110-18-002364.hdr.sgml : 20180220
20180220160224
ACCESSION NUMBER: 0001179110-18-002364
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180215
FILED AS OF DATE: 20180220
DATE AS OF CHANGE: 20180220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Enyedy Mark J
CENTRAL INDEX KEY: 0001586965
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17999
FILM NUMBER: 18624525
MAIL ADDRESS:
STREET 1: C/O FATE THERAPEUTICS, INC.
STREET 2: 3535 GENERAL ATOMICS COURT, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMMUNOGEN INC
CENTRAL INDEX KEY: 0000855654
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 042726691
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 830 WINTER ST
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781)895-0600
MAIL ADDRESS:
STREET 1: 830 WINTER ST
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
edgar.xml
FORM 4 -
X0306
4
2018-02-15
0
0000855654
IMMUNOGEN INC
IMGN
0001586965
Enyedy Mark J
24 CONCORD SQUARE
BOSTON
MA
02118
1
1
0
0
Chief Executive Officer
Stock Option (right to buy)
10.65
2018-02-15
4
A
0
1100000
10.65
A
2019-02-15
2028-02-15
Common Stock
1100000
1100000
D
Exercisable in three equal installments over three years starting on the first year anniversary of the grant.
/s/ Craig Barrows, attorney in fact
2018-02-20